ExodusPoint Capital Management, LP

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 1736225 NEW YORK, NY

Back to KNSA Full portfolio

Position in KNSA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,111,437

-$406,952 QoQ

Shares Held

33,017

-36.9% QoQ

Ownership

0.021%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#92

of 266 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in KNSA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ExodusPoint Capital Management, LP holds $55,176,557 across 18 Drug Manufacturers - Specialty & Generic names. KNSA ranks #6 (3.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LNTH	Lantheus Holdings, Inc.	150,033	$16,644,661
2	ELAN	Elanco Animal Health Inc	446,179	$10,980,465
3	BCRX	Biocryst Pharmaceuticals Inc	744,917	$7,449,170
4	AMRX	Amneal Pharmaceuticals, Inc.	256,843	$4,445,952
5	ANIP	Ani Pharmaceuticals Inc	32,838	$2,718,329
6	KNSA	Kiniksa Pharmaceuticals International, plc This page	33,017	$2,111,437
7	INDV	Indivior Pharmaceuticals, Inc.	49,984	$2,050,843
8	ALKS	Alkermes plc.	31,684	$1,660,241

All Filings in KNSA

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,111,437	33,017	-36.9%	Shares	Sole	2026-08-14
2026-03-31	$2,518,389	52,303	+557.2%	Shares	Sole	2026-05-14
2025-12-31	$328,267	7,958	-86.7%	Shares	Sole	2026-02-17
2025-09-30	$2,324,985	59,876	-55.1%	Shares	Sole	2025-11-14
2025-06-30	$3,687,746	133,276	+311.6%	Shares	Sole	2025-08-13
2025-03-31	$719,204	32,382	-74.5%	Shares	Sole	2025-05-14
2024-12-31	$2,515,244	127,161	+965.2%	Shares	Sole	2025-02-12
2024-09-30	$298,330	11,938	—	Shares	Sole	2024-11-12
No filing history on record for this holder in this stock.